SEC Form 4 · accession 0001651844-16-000020
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Jun 27, 2016
Accepted (ET)
Jul 1, 2016 · 5:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 27, 2016 | P | 3,000 | $3.42 | A | 2,833,050 | D | |
| Common Stock | Jun 27, 2016 | P | 1,500 | $3.45 | A | 2,834,550 | D | |
| Common Stock | Jun 27, 2016 | P | 2,500 | $3.40 | A | 2,837,050 | D | |
| Common Stock | Jun 28, 2016 | P | 3,500 | $3.74 | A | 2,840,550 | D | |
| Common Stock | Jun 28, 2016 | P | 2,500 | $3.71 | A | 2,843,050 | D | |
| Common Stock | Jun 29, 2016 | P | 3,000 | $3.45 | A | 2,846,050 | D | |
| Common Stock | Jun 29, 2016 | P | 1,500 | $3.36 | A | 2,847,550 | D | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.